COVID-19疫苗接种与月经周期特征:一项前瞻性队列研究
该前瞻性队列研究纳入2021年1月至2022年8月间妊娠在线研究(PRESTO)中1,137名21-45岁美国或加拿大居民,未接受生育治疗且正在尝试受孕,通过问卷收集COVID-19疫苗接种与月经周期特征。接种第一剂后月经周期延长1.1天(95%CI:0.4,1.9),第二剂后延长1.3天(95%CI:0.2,2.5),第二个月经周期后关联减弱。未观察到疫苗接种与周期规律性、出血长度、出血量或经期疼痛的强关联。
要点
- 接种第一剂COVID-19疫苗后月经周期延长1.1天(95%CI:0.4,1.9)。
- 接种第二剂后月经周期延长1.3天(95%CI:0.2,2.5)。
- 疫苗接种与周期规律性、出血长度、出血量或经期疼痛无强关联。
核心结论
- COVID-19疫苗接种与月经周期长度约1天的暂时性增加相关,但与其他月经周期特征无明显关联。
研究设计与样本
- 研究为基于互联网的前瞻性队列研究,样本来自2021年1月至2022年8月纳入妊娠在线研究(PRESTO)的1,137名参与者,年龄21-45岁,美国或加拿大居民,未接受生育治疗且正在尝试受孕。
- 参与者在基线和每8周(最长12个月)完成问卷,提供COVID-19疫苗接种和月经周期特征信息。
主要发现
- 接种第一剂COVID-19疫苗后月经周期延长1.1天(95%CI:0.4,1.9),接种第二剂后延长1.3天(95%CI:0.2,2.5)。
- 疫苗接种后的第二个月经周期,关联减弱。
- 未观察到COVID-19疫苗接种与周期规律性、出血长度、出血量或经期疼痛的强关联。
关键数值与推荐
- 采用广义估计方程(GEE)模型,对数链接和泊松分布估计不规则周期的调整风险比(RR)。
- 采用线性回归与GEE估计月经周期长度的调整均值差。
- 调整了社会人口学、生活方式、医学和生殖因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We prospectively examined the association between COVID-19 vaccination and menstrual cycle characteristics in an internet-based prospective cohort study. We included a sample of 1,137 participants who enrolled in Pregnancy Study Online (PRESTO), a preconception cohort study of couples trying to conceive, during January 2021-August 2022. Eligible participants were aged 21-45 years, United States or Canadian residents, and trying to conceive without fertility treatment. At baseline and every 8 weeks for up to 12 months, participants completed questionnaires on which they provided information on COVID-19 vaccination and menstrual cycle characteristics, including cycle regularity, cycle length, bleed length, heaviness of bleed, and menstrual pain. We fit generalized estimating equation (GEE) models with a log link function and Poisson distribution to estimate the adjusted risk ratio (RR) for irregular cycles associated with COVID-19 vaccination. We used linear regression with GEE to estimate adjusted mean differences in menstrual cycle length associated with COVID-19 vaccination. We adjusted for sociodemographic, lifestyle, medical and reproductive factors. Participants had 1.1 day longer menstrual cycles after receiving the first dose of COVID-19 vaccine (95 % CI: 0.4, 1.9) and 1.3 day longer cycles after receiving the second dose (95 % CI: 0.2, 2.5). Associations were attenuated at the second cycle post-vaccination. We did not observe strong associations between COVID-19 vaccination and cycle regularity, bleed length, heaviness of bleed, or menstrual pain. In conclusion, COVID-19 vaccination was associated with a ∼1 day temporary increase in menstrual cycle length, but was not appreciably associated with other menstrual cycle characteristics.
引用
- Wesselink AK, Lovett SM, Weinberg J, et al. COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study. Vaccine. 2023. PMID: 37301706. doi:10.1016/j.vaccine.2023.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。